SEC Form 4 · accession 0001193125-26-296160
PROKIDNEY CORP. · PROK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Thomas Locke
Officer — Chief Technical Officer
Period of report
Jul 1, 2026
Accepted (ET)
Jul 6, 2026 · 4:02 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001850270
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $1.89 | Jul 1, 2026 | A | 750,000 | A | — | Jul 1, 2036 | Class A Common Stock | 750,000 | 750,000 | D |
Explanation of responses
- F1The option vests 25% on 1st anniversary of July 1, 2026 and the remaining 75% vests in substantially equal monthly installments for 36 months thereafter, subject to continued employment.